
Rachel Fishman Oiknine, MD, MSCP
Quick Facts
| Practice Type | Concierge |
| Location | St. Louis, Chesterfield |
| Doctors | Rachel Fishman Oiknine MD, MSCP, Endocrinology |
About
At Rachel Fishman Oiknine, MD, MSCP, a board-certified endocrinologist brings specialized expertise to concierge primary care in Chesterfield, Missouri. Dr. Rachel Fishman Oiknine holds dual credentials in endocrinology and menopause care, making her clinical focus unusually specific for this model. She takes a whole-body approach, recognizing that endocrine disorders can affect nearly every organ system.
The practice delivers the MDVIP Wellness Program, which includes 18 or more advanced screenings and diagnostic tests. These screenings help identify risk markers for conditions like heart disease and diabetes. Dr. Fishman Oiknine treats a wide range of conditions including thyroid disease, osteoporosis, metabolic syndrome, obesity, and type 2 diabetes. She also serves as a dedicated menopause specialist, offering both hormonal and non-hormonal treatment options. Her philosophy centers on shared decision-making, evidence-based guidance, and long-term prevention. She holds a hospital affiliation with St. Luke's Hospital in St. Louis.
Details
Address
222 South Woods Mill Road, Suite 410 North, Chesterfield, MO
Phone
866.696.3847Website
Visit websiteOur Doctors
Similar Practices Nearby

Christine Sigman, MD, ABAARM
Internal Medicine, Functional Medicine, Preventive Medicine

Robert Saltman, MD - Concierge Internal Medicine
Internal Medicine, Preventive Medicine, Endocrinology

Barbara Jost, MD - Concierge Internal Medicine
Internal Medicine, Preventive Medicine
Explore More
Frequently Asked Questions
The annual membership fee covers the MDVIP Wellness Program, which includes 18 or more advanced screenings and diagnostic tests. These tests help identify risk markers for conditions such as heart disease and diabetes. Members can pay the fee quarterly at $650, semi-annually at $1,300, or annually at $2,600.
Yes, the practice accepts insurance for standard medical services such as sick visits. Insurance does not cover the annual membership fee, which funds preventive services and advanced screenings that most insurance plans exclude. Dr. Fishman Oiknine's office can confirm whether they accept your specific plan.
Yes. Members can reach Dr. Fishman Oiknine by phone after hours and on weekends. The practice offers same-day and next-day appointments during regular office hours, Monday through Friday, 9:00 AM to 4:30 PM.
The practice focuses on endocrinology and menopause care, with particular emphasis on thyroid disease, osteoporosis, metabolic syndrome, type 2 diabetes, obesity, and cardiovascular disease prevention. Dr. Fishman Oiknine also provides comprehensive menopause management, including both hormonal and non-hormonal treatment options.
The MDVIP Wellness Program includes 18 or more advanced screenings and diagnostic tests. These tests help identify risk markers for serious conditions including heart disease and diabetes. The annual membership fee covers this program.
The practice serves adult patients. Dr. Fishman Oiknine has a particular focus on women navigating menopause and adults managing hormone-related or metabolic conditions. Patients with thyroid disease, osteoporosis, type 2 diabetes, or cardiovascular risk factors are well-suited for her clinical approach.
Prospective patients can request a meeting with Dr. Fishman Oiknine before joining. This get-to-know-you step lets both doctor and patient determine whether the practice is a good fit. You can submit a request directly through the MDVIP website or call the Chesterfield office.
Dr. Fishman Oiknine brings board-certified endocrinology expertise and the MSCP credential to her concierge practice. The combination of specialized hormonal and metabolic care with the comprehensive MDVIP Wellness Program sets this practice apart. Members also gain access to MDVIP's broader network, including connections to specialists at leading medical institutions when needed.
Practice last updated April 9, 2026


